Skip to main content
. 2023 Mar 28;146(6):2570–2583. doi: 10.1093/brain/awad101

Figure 4.

Figure 4

Simoa N4PB measurements in prion disease and at-risk cohorts. (A) Plasma N4PB levels, where only GFAP and NfL showed statistically significant different mean values between IPD at-risk and disease groups. (B) CSF N4PB levels, where only NfL showed statistically significant different mean values between IPD at-risk and disease groups.